Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Epidemiology, Incidence and Mortality of Breast Cancer in Asia

  • Ghoncheh, Mahshid (Department of Epidemiology & Biostatistics, School of Public Health, Hamadan University of Medical Sciences) ;
  • Mahdavifar, Neda (Health Promotion Research Center, Department of Epidemiology & Biostatistics, School of Public Health, Zahedan University of Medical Sciences) ;
  • Darvishi, Efat (Ahvaz Jundishapur University of Medical Sciences) ;
  • Salehiniya, Hamid (Zabol University of Medical Sciences)
  • Published : 2016.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Breast cancer is the most common malignancy in women in Asia and its incidence is rapidly increasing. Information on the incidence and mortality of breast cancer is essential for planning health and more studies. This study aimed to investigate the age-specific incidence and mortality of breast cancer in Asia in 2012. A total of 639,824 cases of breast cancer were recorded in Asian countries, those with the five highest standardized incidence rates being Israel, Lebanon, Armenia, Singapore, and Kazakhstan. The highest number of deaths was observed in India, China, Indonesia, Pakistan, and Japan, respectively. Tith increasing income and improving living standards in developing countries, the incidence of breast cancer increases. This may be due to longer life, higher exposure to risk factors, eating more fatty foods and obesity, and lower pregnancy rates. The variation in incidence rates of breast cancer is very pronounced in Asia (from 80.5 in Israel to 4.6 in Bhuta). A similar situation exists for mortality rates (from 1.8 in Bhutan to 25.2 in Pakistan).

Keywords

References

  1. Agarwal G, Pradeep P, Aggarwal V, et al (2007). Spectrum of breast cancer in Asian women. World J Surg, 31, 1031-40. https://doi.org/10.1007/s00268-005-0585-9
  2. Bhoo-Pathy N, Hartman M, Yip C-H, et al (2012). Ethnic differences in survival after breast cancer in South East Asia. PLoS One, 7, e309-95.
  3. Bongaarts J, Sinding S (2011). Population policy in transition in the developing world. Science, 333, 574-6. https://doi.org/10.1126/science.1207558
  4. CH Y (2009). Breast Cancer in Asia. In: Verma M. eds. Methods inMolecular Biology, Cancer Epidemiolog. Totowa, NJ:Springer Science, 471, 51-64.
  5. Choi Y, Kim YJ, Shin HR, et al (2005). Long-term prediction of female breast cancer mortality in Korea. Asian Pac J Cancer Prev, 6, 16-21.
  6. DeSantis CE, Bray F, Ferlay J, et al (2015). International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev, 24, 1495-506. https://doi.org/10.1158/1055-9965.EPI-15-0535
  7. Fan L, Zheng Y, Yu KD, et al (2009). Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat, 117, 409-16. https://doi.org/10.1007/s10549-008-0303-z
  8. Ferlay J SI, Ervik M, Dikshit R, et al. 2013a. Globocan 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer [Online]. Available: Available from: http://globocan.iarc.fr, accessed on 7/JUNE/2015.
  9. Ferlay J SI, Ervik M, Dikshit R,et al ( 2013b). GLOBOCAN 2012 v1.0, Cancer Incidence and MortalityWorldwide: IARC CancerBase No. 11 [Internet]. Lyon, France:International Agency for Research on Cancer. International Agency for Research on Cancer.
  10. Gao YT, Shu XO, Dai Q, et al (2000). Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer, 87, 295-300. https://doi.org/10.1002/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7
  11. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H (2015). IncidencE AND MORTALITY OF BREAST CANCER AND THEIR RELATIONSHIP TO DEVELOPMEnt in Asia. Asian Pac J Cancer Prev, 16, 6081-7. https://doi.org/10.7314/APJCP.2015.16.14.6081
  12. Green M, Raina V (2008). Epidemiology, screening and diagnosis of breast cancer in the Asia-Pacific region: current perspectives and important considerations. Asia Pac J Clin Oncol, 4, S5-S13. https://doi.org/10.1111/j.1743-7563.2008.00191.x
  13. Guo P, Huang Z, Yu P, et al (2012). Trends in cancer mortality in China: an update. Ann Oncol, 23, 2755-62. http://globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp. https://doi.org/10.1093/annonc/mds069
  14. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  15. Keramatinia A, Mousavi-Jarrahi SA, Hiteh M, et al (2014). Trends in incidence of breast cancer among women under 40 in Asia. Asian Pac J Cancer Prev, 15, 1387-90. https://doi.org/10.7314/APJCP.2014.15.3.1387
  16. Kwong A, Mang OW, Tam AH, et al (2015). Abstract P3-07-32: Breast cancer in Hong Kong, Southern China: The population-based, ten-year analysis of epidemiological characteristics, stage-specific, cancer-specific, & disease-free survival in breast cancer patients: 1997-2006. Cancer Res, 75, P3-07-32-P3-07-32. https://doi.org/10.1158/0008-5472.CAN-14-3532
  17. Leong SP, Shen ZZ, Liu TJ, et al (2010). Is breast cancer the same disease in Asian and Western countries. World J Surg, 34, 2308-24. https://doi.org/10.1007/s00268-010-0683-1
  18. Lertkhachonsuk Aa, Yip CH, Khuhaprema T, et al (2013). Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol, 14, e497-e507. https://doi.org/10.1016/S1470-2045(13)70350-4
  19. Liu YT, Gao CM, Ding JH, et al (2011). Physiological, reproductive factors and breast cancer risk in Jiangsu province of China. Asian Pac J Cancer Prev, 12, 787-90.
  20. Nagata C, Hu YH, Shimizu H (1995). Effects of Menstrual and Reproductive Factors on the Risk of Breast Cancer: Meta-analysis of the Case-Control Studies in Japan. Cancer Science, 86, 910-5.
  21. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  22. Parkin DM, Fernandez LM (2006). Use of statistics to assess the global burden of breast cancer. Breast J, 12, S70-S80. https://doi.org/10.1111/j.1075-122X.2006.00205.x
  23. Rahimzadeh M, Baghestani AR, Gohari MR, et al (2013). Estimation of the cure rate in Iranian breast cancer patients. Asian Pac J Cancer Prev, 15, 4839-42.
  24. Shin H-R, Joubert C, Boniol M, et al (2010). Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women. Cancer Causes Control, 21, 1777-85. https://doi.org/10.1007/s10552-010-9604-8
  25. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
  26. Suh JS, Yoo KY, Kwon OJ, et al (1996). Menstrual and reproductive factors related to the risk of breast cancer in Korea. J Korean Med Sci, 11, 501-8. https://doi.org/10.3346/jkms.1996.11.6.501
  27. Toi M, Ohashi Y, Seow A, et al (2010). The Breast cancer working group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer. Jpn J Clin Oncol, 40, i13-i8. https://doi.org/10.1093/jjco/hyq122
  28. Troisi R, Altantsetseg D, Davaasambuu G, et al (2012). Breast cancer incidence in Mongolia. Cancer Causes Control, 23, 1047-53. https://doi.org/10.1007/s10552-012-9973-2
  29. United Nations DoEaSA, Division P (2011). United Nations, Department of Economic and Social Affairs,Population Division. World Population Prospects: The 2010Revision, CD-ROM Edition; 2011. World Population Prospects.
  30. WHO(2014). World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014. 2014 [cited 2015; Available from: http://www.who.int/nmh/countries/fji_en.pdf?ua=1.Online.
  31. Yanhua C, Geater A, You J, et al (2012). Reproductive variables and risk of breast malignant and benign tumours in Yunnan province, China. Asian Pac J Cancer Prev, 13, 2179-84. https://doi.org/10.7314/APJCP.2012.13.5.2179
  32. Youlden DR, Cramb SM, Dunn NA, et al (2012). The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol, 36, 237-48. https://doi.org/10.1016/j.canep.2012.02.007
  33. Youlden DR, Cramb SM, Yip CH, et al (2014). Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med, 11, 101.
  34. Zeng H, Zheng R, Zhang S, et al (2014). Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries. J Thorac Dis, 6, 466.

Cited by

  1. Immunoexpression of P63 and SOX2 in triple-negative breast cancers, Indonesia vol.6, pp.2046-1402, 2017, https://doi.org/10.12688/f1000research.12671.1
  2. Immunoexpression of P63 and SOX2 in triple-negative breast cancers, Indonesia vol.6, pp.2046-1402, 2017, https://doi.org/10.12688/f1000research.12671.2
  3. An insight into clinical outcome of XPG polymorphisms in breast cancer pp.1573-4978, 2018, https://doi.org/10.1007/s11033-018-4401-7
  4. Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience vol.12, pp.1179-5549, 2018, https://doi.org/10.1177/1179554918782475
  5. Vanadium quercetin complex attenuates mammary cancer by regulating the P53, Akt/mTOR pathway and downregulates cellular proliferation correlated with increased apoptotic events vol.31, pp.4, 2018, https://doi.org/10.1007/s10534-018-0117-3